Related Experiment Video

Updated: Jun 25, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

How to use virological tools for optimal management of chronic hepatitis C

Stéphane Chevaliez1, Jean-Michel Pawlotsky

  • 1Department of Virology & INSERM U841, French National Reference Center for Viral Hepatitis B, C and delta, Hôpital Henri Mondor, Université Paris 12, Créteil, France.

Liver International : Official Journal of the International Association for the Study of the Liver
|February 12, 2009
PubMed

Insights

Virological assays are essential for diagnosing and managing chronic hepatitis C (HCV). These tests, including antibody detection, viral load measurement, and genotyping, guide treatment decisions and predict outcomes for patients with HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Diagnostics

Background:

  • Chronic hepatitis C (HCV) is a significant global health concern, potentially leading to cirrhosis and hepatocellular carcinoma.
  • Current antiviral therapies for HCV exhibit moderate effectiveness.
  • Accurate diagnosis and patient management are critical for improving treatment outcomes.

Purpose of the Study:

  • To highlight the indispensable role of virological assays in the diagnosis and management of chronic hepatitis C.
  • To discuss the utility of various HCV virological assays in clinical decision-making.
  • To emphasize the importance of viral load monitoring and genotyping for optimizing treatment strategies.

Main Methods:

  • Review of available virological assays for hepatitis C virus (HCV) diagnosis and management.
  • Discussion of molecular biology techniques for HCV RNA quantification, including target amplification (e.g., PCR) and signal amplification (e.g., branched DNA).
  • Overview of methods for HCV genotyping and their clinical applications.

Main Results:

  • Virological assays, including anti-HCV antibody tests, HCV RNA viral load measurement, and HCV genotyping, are crucial for diagnosing and managing HCV infections.
  • Monitoring viral kinetics through HCV RNA assays during antiviral treatment informs critical decisions regarding treatment duration and stopping rules.
  • Pretreatment HCV genotyping provides prognostic information and aids in optimizing treatment length and ribavirin dosage, as treatment response varies by genotype.

Conclusions:

  • Virological assays are indispensable tools for the comprehensive diagnosis and management of patients with chronic hepatitis C.
  • Effective utilization of HCV RNA viral load monitoring and genotyping significantly enhances treatment personalization and efficacy.
  • These assays are vital for predicting treatment outcomes and guiding therapeutic adjustments in HCV management.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...